°£Æí°áÁ¦, ½Å¿ëÄ«µå û±¸ÇÒÀÎ
ÀÎÅÍÆÄÅ© ·Ôµ¥Ä«µå 5% (38,480¿ø)
(ÃÖ´ëÇÒÀÎ 10¸¸¿ø / Àü¿ù½ÇÀû 40¸¸¿ø)
ºÏÇǴϾð ·Ôµ¥Ä«µå 30% (28,350¿ø)
(ÃÖ´ëÇÒÀÎ 3¸¸¿ø / 3¸¸¿ø ÀÌ»ó °áÁ¦)
NH¼îÇÎ&ÀÎÅÍÆÄÅ©Ä«µå 20% (32,400¿ø)
(ÃÖ´ëÇÒÀÎ 4¸¸¿ø / 2¸¸¿ø ÀÌ»ó °áÁ¦)
Close

SMART(½º¸¶Æ®) ³»°ú Vol 1: ¹ÙÀÌÅ», °¨¿°, Á¾¾ç, ·ù¸¶Æ¼½º : Pathophysiology to Practice

¼Òµæ°øÁ¦

2013³â 9¿ù 9ÀÏ ÀÌÈÄ ´©Àû¼öÄ¡ÀÔ´Ï´Ù.

ÆǸÅÁö¼ö 91
?
ÆǸÅÁö¼ö¶õ?
»çÀÌÆ®ÀÇ ÆǸŷ®¿¡ ±â¹ÝÇÏ¿© ÆǸŷ® ÃßÀ̸¦ ¹Ý¿µÇÑ ÀÎÅÍÆÄÅ© µµ¼­¿¡¼­ÀÇ µ¶¸³ÀûÀÎ ÆǸŠÁö¼öÀÔ´Ï´Ù. ÇöÀç °¡Àå Àß Æȸ®´Â »óÇ°¿¡ °¡ÁßÄ¡¸¦ µÎ¾ú±â ¶§¹®¿¡ ½ÇÁ¦ ´©Àû ÆǸŷ®°ú´Â ´Ù¼Ò Â÷ÀÌ°¡ ÀÖÀ» ¼ö ÀÖ½À´Ï´Ù. ÆǸŷ® ¿Ü¿¡µµ ´Ù¾çÇÑ °¡ÁßÄ¡·Î ±¸¼ºµÇ¾î ÃÖ±ÙÀÇ À̽´µµ¼­ È®Àνà À¯¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù. ÇØ´ç Áö¼ö´Â ¸ÅÀÏ °»½ÅµË´Ï´Ù.
Close
°øÀ¯Çϱâ
Á¤°¡

45,000¿ø

  • 40,500¿ø (10%ÇÒÀÎ)

    450P (1%Àû¸³)

ÇÒÀÎÇýÅÃ
Àû¸³ÇýÅÃ
  • S-Point Àû¸³Àº ¸¶ÀÌÆäÀÌÁö¿¡¼­ Á÷Á¢ ±¸¸ÅÈ®Á¤ÇϽŠ°æ¿ì¸¸ Àû¸³ µË´Ï´Ù.
Ãß°¡ÇýÅÃ
¹è¼ÛÁ¤º¸
  • 4/27(Åä) À̳» ¹ß¼Û ¿¹Á¤  (¼­¿ï½Ã °­³²±¸ »ï¼º·Î 512)
  • ¹«·á¹è¼Û
ÁÖ¹®¼ö·®
°¨¼Ò Áõ°¡
  • À̺¥Æ®/±âȹÀü

  • ¿¬°üµµ¼­

  • »óÇ°±Ç

AD

Ã¥¼Ò°³

¡ºSMART(½º¸¶Æ®) ³»°ú vol.1: ¹ÙÀÌÅ», °¨¿°, Á¾¾ç, ·ù¸¶Æ¼½º¡»´Â ¡´½ÉÆó¼Ò»ý¼úÀ» ½ÃÇàÇÏÀÚ¡µ, ¡´Ç÷¾ÐÀÌ ºÒ¾ÈÁ¤ÇÑ °æ¿ì: ÃâÇ÷, ¼îÅ© ¹× ¼ö¾×¼Ò»ý¼ú¡µ, ¡´È£ÈíÀÌ ºÒ¾ÈÁ¤ÇÑ °æ¿ì: ±âµµ ¹× ȯ±â°ü¸®¡µ, ¡´¸Æ¹ÚÀÌ ºÒ¾ÈÁ¤ÇÑ °æ¿ì: ½É¹Ú¼ö/½ÉÀ帮µëÀå¾Ö¡µµîÀ» ¼ö·ÏÇÏ°í Àִ åÀÌ´Ù.

ÃâÆÇ»ç ¼­Æò

Ã¥À» º¸½Ã±â Àü¿¡

¡Ü BCU(Barunlab Contents Universe)¿¡ ´ëÇؼ­ ¼Ò°³ÇÕ´Ï´Ù.

¾È³çÇϼ¼¿ä. º» Ã¥ÀÇ ÀúÀÚÀÌÀÚ ¹Ù¸¥ÀÇÇבּ¸¼Ò¸¦ ÅëÇØ ²ÞÀ» ½ÇÇöÇسª°¡°í ÀÖ´Â ÀÌ»óºÀÀÔ´Ï´Ù.
Àú´Â ÀÇÇÐÄÜÅÙÃ÷¿¡ °üÇÑ ÀüüÀûÀÎ ·Îµå¸ÊÀ» ¼³°èÇÏ°í ÀÏÂ÷Áø·á¿¡ °ü·ÃµÈ ´ëºÎºÐÀÇ À̽´¸¦ ÃÑ ¸Á¶óÇÏ´Â ÄÜÅÙÃ÷¸¦ Á¦°øÇÏ°íÀÚ Èû¾²°í ÀÖ½À´Ï´Ù.
ÃÖ±Ù ÀÌ·± öÇРȤÀº ¼¼°è°üÀ» BCU(Barunlab Contents Universe)¶ó´Â À̸§¿¡ ´ã¾Æ³»°Ô µÇ¾ú½À´Ï´Ù.

- Objective : Primary care total package
¹Ù¸¥ÀÇÇבּ¸¼Ò´Â ÀÏÂ÷Áø·á¿¡ ´ëÇÑ total solution Á¦½Ã¸¦ ¸ñÇ¥·Î ÇÕ´Ï´Ù.
ÀÇ´ë»ýºÎÅÍ ¼ö·ÃÀÇ(ÀÎÅÏ, ·¹Áö´øÆ®), °øº¸ÀÇ/±ºÀÇ°ü, °³¿øÀÇ/ºÀÁ÷ÀDZîÁö °¢ ½Ã±â, »óȲº°·Î ÀÇ»ç·Î¼­ÀÇ ±âº» ÀÚÁúÀ» °®Ã߸ç Áø·á performance¸¦ Á¦´ë·Î ¹ßÈÖÇϱâ À§ÇØ ÇÊ¿äÇÑ ÄÜÅÙÃ÷¸¦ ü°èÀûÀ¸·Î Á¦°øÇÏ°íÀÚ BCU(Barunlab Contents Universe)¶ó´Â ·Îµå¸ÊÀ» ¼³°èÇÏ¿´½À´Ï´Ù.
Total soulution Á¦½Ã¸¦ À§ÇØ °¢ stageº°·Î ÀûÇÕÇÑ, °¢ stage³¢¸® ¿¬°áµÇ´Â Áï, ¿¬¼ÓÀûÀ¸·Î ¿¬°üµÇ´Â ÄÜÅÙÃ÷¸¦ ü°èÀûÀ¸·Î Á¦°øÇϱâ À§ÇÑ ÀüüÀûÀÎ ÀÇÇÐ ÄÜÅÙÃ÷ ·Îµå¸ÊÀÔ´Ï´Ù.

- Strategy

Strategy I

Backbone plus supplement Strategy :
Áß½ÉÃà(»À´ë) + Supplement Àü·«

Áß½ÉÃà(»À´ë): ÀÏÂ÷Áø·á¿¡ °üÇÑ ±âº»ÀûÀÌ°í ÀüüÀûÀÎ »À´ë ±¸Ãà
+
Supplement: Ãß°¡ÀûÀ¸·Î ÇÊ¿äÇÑ ¼¼ºÎÀûÀÎ ºÎºÐ º¸Ãæ

Æ÷°ýÀûÀ¸·Î ´Ù·é´Ù°í Çصµ ÇÑ ±ÇÀÇ Ã¥¿¡ ¸ðµç ºÎºÐÀ» ¿Ïº®ÇÏ°Ô ´ã¾Æ³¾ ¼ö ¾ø±â¿¡ "Áß½ÉÃà + Supplement" Àü·«À» ÅëÇØ ÃÖ´ëÇÑ ÀÏÂ÷Áø·áÀÇ ÁÖ¿ä ¿µ¿ªÀ» ü°èÀûÀ¸·Î ´Ù·ç°íÀÚ ÇÕ´Ï´Ù.
BCU´Â ÀÏÂ÷Áø·á¿¡ ´ëÇÑ total solution Á¦½Ã¸¦ À§ÇØ ½º¸¶Æ® ÀÏÂ÷Áø·á¸Å´º¾ó(±Ù°ÅÆí, ½ÇÀüÆí)À» Áß½ÉÃàÀ¸·Î, ¿©·¯ °ü·Ã º¸Ãæ ÄÜÅÙÃ÷¿ÍÀÇ ¿¬°è¿¡ ÃÊÁ¡À» µÎ¾ú½À´Ï´Ù.

Strategy II

Basic to Bedside Strategy or Principle to Practice
±âÃÊÀÇÇп¡¼­ ½ÀµæÇÑ ³»¿ëÀ» ÀÓ»ó¿¡ ÀûÀýÇÏ°Ô Á¢¸ñÇÏ°í È°¿ëÇÒ ¼ö ÀÖµµ·Ï
±âÃʺÎÅÍ ÀÓ»ó±îÁöÀÇ ¿¬¼Ó¼ºÀ» ¿°µÎ¿¡ µÎ¾ú½À´Ï´Ù.

Strategy III

Primary care to Specialized care
¿ì¼± ÀÏÂ÷Áø·á¸¦ ¸¶½ºÅÍÇÏ´Â µ¥ ÁÖ¾ÈÁ¡À» ÁÖ¾ú½À´Ï´Ù.
ÇÑ¹ß ´õ ³ª¾Æ°¡ ÀÏÂ÷Áø·á¸¦ µÑ·¯½Ñ
Àü¹®Áø·áÀÇ ¿µ¿ª±îÁö Á¡Â÷ È®ÀåÇسª°¥ ¿¹Á¤ÀÔ´Ï´Ù.

¡Ü °¨º°Áø´ÜÀÇ Á¤¼®

o ½º¸¶Æ® ³»°ú´Â Strategy III: Primary care to Specialized care¿¡¼­ Specialized care¿¡ ÇØ´çÇϴ åÀÔ´Ï ´Ù. ³»°ú¿¡ ÁßÁ¡À» µÎ°í ÀÏÂ÷Áø·á»Ó ¾Æ´Ï¶ó 3Â÷º´¿ø ¿Ü·¡Áø·á, ÀÔ¿øÁø·á¿Í ¿¬°üµÈ Àü¹®Áø·á¿µ¿ª±îÁö ¸Á¶ó ÇÑ Ã¥ÀÔ´Ï´Ù.
o º» ±³Àç´Â Qbook, ½º¸¶Æ® ³»°úÁø·á¸Å´º¾ó(2021³â ÇϹݱâ Ãâ°£¿¹Á¤)°ú Æ®·ÎÀÌÄ«¸¦ ÀÌ·ç´Â Ã¥À̱⵵ ÇÕ´Ï´Ù.
1. ½º¸¶Æ® ³»°ú: º¸´Ù ±âº»ÀûÀÎ ³»¿ë¿¡ ÃÊÁ¡À» ¸ÂÃá Ã¥
2. ½º¸¶Æ® ³»°úÁø·á¸Å´º¾ó: º¸´Ù ½ÇÀüÀûÀÎ ³»¿ë¿¡ ÃÊÁ¡À» ¸ÂÃá Ã¥
3. Q book: Áõ·Ê Áß½ÉÀ¸·Î ÀÌ·ÐÀ» ½ÇÀü¿¡ Á¢¸ñ½ÃÄÑ Áִ å

ÃÊÆÇÀÌ ºÎÁ·ÇÑ ºÎºÐÀ» Å©°Ô °³¼±Çß½À´Ï´Ù. ³»°úÁø·á ¹× ÀÏÂ÷Áø·áÀÇ ±âº»±â¸¦ ´ÙÁö´Â µ¥ À¯¿ëÇÑ Ã¥ÀÌ µÇ±æ ±â´ëÇÕ´Ï´Ù.

¡Ü BCU(Barunlab Contents Universe)¿¡ ´ëÇؼ­ ¼Ò°³ÇÕ´Ï´Ù.
¾È³çÇϼ¼¿ä. º» Ã¥ÀÇ ÀúÀÚÀÌÀÚ ¹Ù¸¥ÀÇÇבּ¸¼Ò¸¦ ÅëÇØ ²ÞÀ» ½ÇÇöÇسª°¡°í ÀÖ´Â ÀÌ»óºÀÀÔ´Ï´Ù.
Àú´Â ÀÇÇÐÄÜÅÙÃ÷¿¡ °üÇÑ ÀüüÀûÀÎ ·Îµå¸ÊÀ» ¼³°èÇÏ°í ÀÏÂ÷Áø·á¿¡ °ü·ÃµÈ ´ëºÎºÐÀÇ À̽´¸¦ ÃÑ ¸Á¶óÇÏ´Â ÄÜÅÙÃ÷¸¦ Á¦°øÇÏ°íÀÚ Èû¾²°í ÀÖ½À´Ï´Ù.
ÃÖ±Ù ÀÌ·± öÇРȤÀº ¼¼°è°üÀ» BCU(Barunlab Contents Universe)¶ó´Â À̸§¿¡ ´ã¾Æ³»°Ô µÇ¾ú½À´Ï´Ù.

- Objective : Primary care total package
¹Ù¸¥ÀÇÇבּ¸¼Ò´Â ÀÏÂ÷Áø·á¿¡ ´ëÇÑ total solution Á¦½Ã¸¦ ¸ñÇ¥·Î ÇÕ´Ï´Ù.
ÀÇ´ë»ýºÎÅÍ ¼ö·ÃÀÇ(ÀÎÅÏ, ·¹Áö´øÆ®), °øº¸ÀÇ/±ºÀÇ°ü, °³¿øÀÇ/ºÀÁ÷ÀDZîÁö °¢ ½Ã±â, »óȲº°·Î ÀÇ»ç·Î¼­ÀÇ ±âº» ÀÚÁúÀ» °®Ã߸ç Áø·á performance¸¦ Á¦´ë·Î ¹ßÈÖÇϱâ À§ÇØ ÇÊ¿äÇÑ ÄÜÅÙÃ÷¸¦ ü°èÀûÀ¸·Î Á¦°øÇÏ°íÀÚ BCU(Barunlab Contents Universe)¶ó´Â ·Îµå¸ÊÀ» ¼³°èÇÏ¿´½À´Ï´Ù.
Total soulution Á¦½Ã¸¦ À§ÇØ °¢ stageº°·Î ÀûÇÕÇÑ, °¢ stage³¢¸® ¿¬°áµÇ´Â Áï, ¿¬¼ÓÀûÀ¸·Î ¿¬°üµÇ´Â ÄÜÅÙÃ÷¸¦ ü°èÀûÀ¸·Î Á¦°øÇϱâ À§ÇÑ ÀüüÀûÀÎ ÀÇÇÐ ÄÜÅÙÃ÷ ·Îµå¸ÊÀÔ´Ï´Ù.

- Strategy

Strategy I

Backbone plus supplement Strategy :
Áß½ÉÃà(»À´ë) + Supplement Àü·«

Áß½ÉÃà(»À´ë): ÀÏÂ÷Áø·á¿¡ °üÇÑ ±âº»ÀûÀÌ°í ÀüüÀûÀÎ »À´ë ±¸Ãà
+
Supplement: Ãß°¡ÀûÀ¸·Î ÇÊ¿äÇÑ ¼¼ºÎÀûÀÎ ºÎºÐ º¸Ãæ

Æ÷°ýÀûÀ¸·Î ´Ù·é´Ù°í Çصµ ÇÑ ±ÇÀÇ Ã¥¿¡ ¸ðµç ºÎºÐÀ» ¿Ïº®ÇÏ°Ô ´ã¾Æ³¾ ¼ö ¾ø±â¿¡ ¡°Áß½ÉÃà + Supplement¡± Àü·«À» ÅëÇØ ÃÖ´ëÇÑ ÀÏÂ÷Áø·áÀÇ ÁÖ¿ä ¿µ¿ªÀ» ü°èÀûÀ¸·Î ´Ù·ç°íÀÚ ÇÕ´Ï´Ù.
BCU´Â ÀÏÂ÷Áø·á¿¡ ´ëÇÑ total solution Á¦½Ã¸¦ À§ÇØ ½º¸¶Æ® ÀÏÂ÷Áø·á¸Å´º¾ó(±Ù°ÅÆí, ½ÇÀüÆí)À» Áß½ÉÃàÀ¸·Î, ¿©·¯ °ü·Ã º¸Ãæ ÄÜÅÙÃ÷¿ÍÀÇ ¿¬°è¿¡ ÃÊÁ¡À» µÎ¾ú½À´Ï´Ù.

Strategy II

Basic to Bedside Strategy or Principle to Practice
±âÃÊÀÇÇп¡¼­ ½ÀµæÇÑ ³»¿ëÀ» ÀÓ»ó¿¡ ÀûÀýÇÏ°Ô Á¢¸ñÇÏ°í È°¿ëÇÒ ¼ö ÀÖµµ·Ï
±âÃʺÎÅÍ ÀÓ»ó±îÁöÀÇ ¿¬¼Ó¼ºÀ» ¿°µÎ¿¡ µÎ¾ú½À´Ï´Ù.

Strategy III

Primary care to Specialized care
¿ì¼± ÀÏÂ÷Áø·á¸¦ ¸¶½ºÅÍÇÏ´Â µ¥ ÁÖ¾ÈÁ¡À» ÁÖ¾ú½À´Ï´Ù.
ÇÑ¹ß ´õ ³ª¾Æ°¡ ÀÏÂ÷Áø·á¸¦ µÑ·¯½Ñ
Àü¹®Áø·áÀÇ ¿µ¿ª±îÁö Á¡Â÷ È®ÀåÇسª°¥ ¿¹Á¤ÀÔ´Ï´Ù.

¡Ü °¨º°Áø´ÜÀÇ Á¤¼®
¤ý ½º¸¶Æ® ³»°ú´Â Strategy III: Primary care to Specialized care¿¡¼­ Specialized care¿¡ ÇØ´çÇϴ åÀÔ´Ï ´Ù. ³»°ú¿¡ ÁßÁ¡À» µÎ°í ÀÏÂ÷Áø·á»Ó ¾Æ´Ï¶ó 3Â÷º´¿ø ¿Ü·¡Áø·á, ÀÔ¿øÁø·á¿Í ¿¬°üµÈ Àü¹®Áø·á¿µ¿ª±îÁö ¸Á¶ó ÇÑ Ã¥ÀÔ´Ï´Ù.
¤ý º» ±³Àç´Â Qbook, ½º¸¶Æ® ³»°úÁø·á¸Å´º¾ó(2021³â ÇϹݱâ Ãâ°£¿¹Á¤)°ú Æ®·ÎÀÌÄ«¸¦ ÀÌ·ç´Â Ã¥À̱⵵ ÇÕ´Ï´Ù.
1. ½º¸¶Æ® ³»°ú: º¸´Ù ±âº»ÀûÀÎ ³»¿ë¿¡ ÃÊÁ¡À» ¸ÂÃá Ã¥
2. ½º¸¶Æ® ³»°úÁø·á¸Å´º¾ó: º¸´Ù ½ÇÀüÀûÀÎ ³»¿ë¿¡ ÃÊÁ¡À» ¸ÂÃá Ã¥
3. Q book: Áõ·Ê Áß½ÉÀ¸·Î ÀÌ·ÐÀ» ½ÇÀü¿¡ Á¢¸ñ½ÃÄÑ Áִ å

ÃÊÆÇÀÌ ºÎÁ·ÇÑ ºÎºÐÀ» Å©°Ô °³¼±Çß½À´Ï´Ù. ³»°úÁø·á ¹× ÀÏÂ÷Áø·áÀÇ ±âº»±â¸¦ ´ÙÁö´Â µ¥ À¯¿ëÇÑ Ã¥ÀÌ µÇ±æ ±â´ëÇÕ´Ï´Ù.

¸ñÂ÷

PART 1. ¹ÙÀÌÅ»
SECTION 1. Cardiac arrest ¡æ ½ÉÆó¼Ò»ý¼úÀ» ½ÃÇàÇÏÀÚ!! -------- 2

1. ½ÉÆó¼Ò»ý¼ú: °³¿ä -------- 3
2. ¼ºÀÎ Àü¹® ½ÉÆó¼Ò»ý¼ú(Advanced Cardiovascular Life Support, ACLS) -------- 15

SECTION 2. Ç÷¾ÐÀÌ ºÒ¾ÈÁ¤ÇÑ °æ¿ì: ÃâÇ÷, ¼îÅ© ¹× ¼ö¾×¼Ò»ý¼ú -------- 32
1. ¼îÅ©: °³¿ä/Ä¡·á ¿øÄ¢ -------- 33
2. ÀúÇ÷·® ¼îÅ©/ÃâÇ÷¼º ¼îÅ©(Hypovolemic shock/Hemorrhagic shock) -------- 43
3. ÆÐÇ÷ ¼îÅ©(Septic shock) -------- 49
4. ½ÉÀ强 ¼îÅ©(Cardiogenic shock) -------- 58
5. ½Å°æ¼º ¼îÅ©(Neurogenic shock) -------- 63
6. ¼ö¾×¿ä¹ý(Fluid therapy) -------- 66
7. ¼öÇ÷¿ä¹ý(Transfusion) -------- 71

SECTION 3. È£ÈíÀÌ ºÒ¾ÈÁ¤ÇÑ °æ¿ì: ±âµµ ¹× ȯ±â°ü¸® -------- 83
1. È£Èí°ï¶õ¿¡ ´ëÇÑ Á¢±Ù -------- 84
2. »ê¼Ò¿ä¹ý -------- 94
3. ±âµµ ȯ±â/°ü¸® -------- 103
o ºñħ½ÀÀû ±âµµ ȯ±â/°ü¸® -------- 104
o ħ½ÀÀû ±âµµ ȯ±â/°ü¸®: ±â°ü »ð°ü -------- 112

SECTION 4. ¸Æ¹ÚÀÌ ºÒ¾ÈÁ¤ÇÑ °æ¿ì: ½É¹Ú¼ö/½ÉÀ帮µëÀå¾Ö -------- 122
1. ¼­¸Æ¿¡ ´ëÇÑ Á¢±Ù -------- 123
2. ºó¸Æ¿¡ ´ëÇÑ Á¢±Ù -------- 126

SECTION 5. ü¿ÂÀÌ»ó¿¡ ´ëÇÑ Á¢±Ù -------- 130
1. ¹ß¿­(Fever) -------- 131
o ¹ß¿­¿¡ ´ëÇÑ Á¢±Ù -------- 132
o ºÒ¸í¿­(Fever of unknown origin) -------- 139
2. Àúü¿Â(Hypothermia) -------- 148

PART 2. °¨¿°
SECTION 1. °¨¿°Áúȯ ±âº» -------- 158

1. ÁÖ¿ä º´¿øü¿¡ ´ëÇÑ ÀÌÇØ -------- 159
2. Ç×»ýÁ¦¿¡ ´ëÇÑ ÀÌÇØ -------- 161
3. ÀÇ·á °ü·Ã °¨¿° -------- 176
o Ä«Å×ÅÍ °ü·Ã °¨¿°(Ä«Å×ÅÍ °ü·Ã ±ÕÇ÷Áõ) -------- 178
o Clostridium difficile Infection [CDI, °ÅÁþ¸·´ëÀå¿°(Pseudomembranous colitis, PMC)] -------- 182

SECTION 2. °¨¿°°ü¸®/¿¹¹æ -------- 185
1. º´¿øüÀÇ Ä§ÀÔÀ» ¸·ÀÚ! -------- 186
2. ÀüÆÄ °úÁ¤À» Â÷´ÜÇÏÀÚ! -------- 195
o Ç¥ÁØÁÖÀÇ(Standard precautions) -------- 196
o ÀüÆÄ°æ·Îº° °Ý¸® ------- 202
3. ¸é¿ª·ÂÀ¸·Î ´ëºñÇÏÀÚ! ¿¹¹æÁ¢Á¾ -------- 206
o ¿¹¹æÁ¢Á¾¿¡ ´ëÇÑ ÀÌÇØ -------- 207
o ¿¹¹æÁ¢Á¾ÀÇ ¿øÄ¢ -------- 210
o ¿¹¹æÁ¢Á¾ ÀÏÁ¤ »ìÆ캸±â! -------- 221

SECTION 3. º´¿øüº°: ¼¼±Õ °¨¿° -------- 227
1. ±×¶÷¾ç¼º±Õ °¨¿° -------- 228
o Æ÷µµ¾Ë±Õ(Staphylococcus) °¨¿° -------- 229
o »ç½½¾Ë±Õ(Streptococcus) °¨¿° -------- 233
o Æó·Å¾Ë±Õ(Pneumococcus) °¨¿° -------- 237
o Àå¾Ë±Õ(Enterococcus) °¨¿° -------- 241
o Corynebacterium °¨¿°: µðÇÁÅ׸®¾Æ(Diphtheria) µî -------- 245
o ¸®½ºÅ׸®¾Æ(Listeria) °¨¿° -------- 249
2. ±×¶÷À½¼º±Õ °¨¿° -------- 252
o Neisseria °¨¿°: ¼ö¸·¾Ë±Õ(Meningococcus) °¨¿° -------- 254
o Neisseria °¨¿°: ÀÓ±Õ(Gonoccocus) °¨¿° -------- 258
o Çì¸ðÇʷ罺/¸ð¶ô¼¿¶ó(Hemophilus/Moraxella) °¨¿° -------- 262
o ³ì³ó±Õ/¿¡½Ã³×Åä¹ÚÅÍ(Pseudomonas/Acinetobacter) °¨¿° -------- 267
o »ì¸ð³Ú¶ó(ÀåƼǪ½º)/½Ã°Ö¶ó(Salmonella/Shigella) °¨¿° -------- 273
o ºñºê¸®¿À(Vibrio) °¨¿°: ÄÝ·¹¶ó/±âŸ ºñºê¸®¿À -------- 280
o ±×¶÷À½¼º Àå³»¼¼±Õ(Gram negative enteric bacteria) °¨¿° -------- 286
o ¹éÀÏÇØ/±âŸ º¸µ¥ÅÚ¶ó °¨¿° -------- 294
o Ä·ÇʷιÚÅÍ/Ç︮ÄÚ¹ÚÅÍ °¨¿° -------- 300
o ·¹Áö¿À³Ú¶ó °¨¿° -------- 304
3. ±âŸ ¼¼±Õ °¨¿° -------- 307
o ¸¶ÀÌÄÚÇöóÁ/Ŭ¶ó¹Ìµð¾Æ °¨¿° -------- 308
o ³ª¼±±Õ(Spirochetes) °¨¿° -------- 316
o ¹Ì»ê¼Ò¼º/¹«»ê¼Ò¼º ¼¼±Õ °¨¿° -------- 321
o ¸®ÄÉÂ÷ °¨¿°: ÂêÂê°¡¹«½Ãº´, Å¥¿­ µî -------- 329
4. ¹ÌÄÚ¹ÚÅ׸®¾Æ(°áÇÙ±Õ) °¨¿° ------- 333
o °áÇÙÀÇ Áø´Ü ¹× Ä¡·á -------- 334
o Àẹ°áÇÙ °¨¿° -------- 349
o ºñ°áÇÙ Ç×»ê±Õ(Non-Tuberculous Mycobacterium, NTM) °¨¿° -------- 355

SECTION 4. ¹ÙÀÌ·¯½º °¨¿° -------- 363
1. »ç¶÷Ç츣Æ佺 ¹ÙÀÌ·¯½º(Herpesviridae) °¨¿° -------- 364
o ´Ü¼øÆ÷Áø ¹ÙÀÌ·¯½º(Herpes simplex virus) °¨¿° -------- 365
o ¼öµÎ-´ë»óÆ÷Áø ¹ÙÀÌ·¯½º(Varicella-Zoster virus) °¨¿° -------- 368
o ¿¦½ºÅ¸Àι٠¹ÙÀÌ·¯½º(Epstein Barr virus) °¨¿° -------- 379
o °Å´ë¼¼Æ÷ ¹ÙÀÌ·¯½º(Cytomegalovirus) °¨¿° -------- 382
2. »ç¶÷À¯µÎÁ¾ ¹ÙÀÌ·¯½º(Human papillomaviruses, HPVs) °¨¿° -------- 386
3. ÀÎÇ÷翣ÀÚ(Influenza) °¨¿° -------- 389
4. Àå ¹ÙÀÌ·¯½º(¿£Å×·Î ¹ÙÀÌ·¯½º, Enterovirus) °¨¿° -------- 397
5. Äڷγª ¹ÙÀÌ·¯½º(Coronavirus) °¨¿° -------- 404
o Äڷγª ¹ÙÀÌ·¯½º °¨¿°: Overview -------- 405
o [Special review] Äڷγª 19(COVID-19) °¨¿° -------- 409
6. ÀϺ»³ú¿° ¹ÙÀÌ·¯½º(Japanese encephalitis virus) -------- 418
7.°ø¼öº´(±¤°ßº´, Rabies)) -------- 421
8. HIV °¨¿°/ÈÄõ¸é¿ª°áÇÌÁõÈıº(AIDS) -------- .. 426
9. ÃÖ±Ù À¯ÇàÇÏ°í ÀÖ´Â ¹ÙÀÌ·¯½º °¨¿°/ÇØ¿ÜÀ¯ÀÔ ¹ÙÀÌ·¯½º °¨¿° -------- 435

SECTION 5. Áø±Õ °¨¿° -------- 442
1. Ä­µð´ÙÁõ(Candidiasis) -------- 443
2. Å©¸³ÅäÄÚÄí½ºÁõ(Cryptococcosis) -------- 448
3. ¾Æ½ºÆ丣±æ·ç½ºÁõ(Aspergillosis) -------- 451
4. ÅаõÆÎÀÌÁõ(Mucormycosis) -------- 456
5. ÆóÆ÷ÀÚÃæÁõ(Pneumocystis jirovecii) -------- 461
6. ±âŸ Áø±Õ °¨¿° -------- 466

SECTION 6. ±â»ýÃæ °¨¿° -------- 475
1. ¿¬Ãæ(Helminths): ¼±Ãæ·ù, ÈíÃæ·ù, Á¶Ãæ·ù -------- 476
2. ¿øÃæ(Protozoa): ¸»¶ó¸®¾Æ µî -------- 486

PART 3. Á¾¾ç
SECTION 1. Á¾¾çÁúȯÀÇ Á¢±Ù -------- 500

[supplement] ¾Ï¿¡ ´ëÇÑ ±âº»ÀûÀÎ ÀÌÇØ -------- 501
1. Á¾¾çÁúȯÀÇ ÀϹÝÀûÀÎ Á¢±ÙÀü·« -------- 504
2. ¾Ï °ËÁø -------- 508
3. Á¾¾ç Ç¥ÁöÀÚ(Tumor marker) -------- 511

SECTION 2. Á¾¾çÁúȯÀÇ Ä¡·á -------- 515
1. ¾Ï Ä¡·á ¿øÄ¢ -------- 516
2. Ä¡·á ¹ÝÀÀÀÇ Æò°¡ -------- 519
3. ¹æ»ç¼± Ä¡·á(Radiotherapy) -------- 525

SECTION 3. Ç×¾ÏÈ­Çпä¹ý -------- 529
1. Ç×¾ÏÈ­Çпä¹ýÀÇ ¿øÄ¢ -------- 530
2. ÁÖ¿ä Ç×¾ÏÁ¦ -------- 533
o Conventional agents/È£¸£¸óÄ¡·áÁ¦ -------- 534
o Ç¥ÀûÄ¡·áÁ¦(Target therapy) -------- 541
o ¸é¿ªÄ¡·áÁ¦(Immunotherapy) -------- 543
3. °¡½¿ ÅëÁõ(Chest pain):Musculoskeletal origin -------- 304

SECTION 4. ¾Ï °ü·Ã Áõ»ó ¹× ÇÕº´Áõ °ü¸® -------- 545
1. ¾Ï¼º ÅëÁõ °ü¸® -------- 546
2. ±¸Á¶Àû/Æó¼â¼º ÇÕº´Áõ -------- 557
o »ó´ëÁ¤¸ÆÁõÈıº(Superior vena cava syndrome) -------- 558
o ¾Ç¼º ô¼ö¾Ð¹ÚÁõÈıº(Malignant spinal cord compression) -------- 559
3. Ä¡·á °ü·Ã ÇÕº´Áõ -------- 560
o Á¾¾ç¿ëÇØÁõÈıº(Tumor lysis syndrome) -------- 560

PART 4. ·ù¸¶Æ¼½º
SECTION 1. ¸é¿ª¸Å°³Áúȯ -------- 564

1. Àü½Å È«¹Ý ·çǪ½º(Systemic lupus erythematosus, SLE) -------- 565
2. Àü½Å °æÈ­Áõ(Systemic sclerosis, SSc) -------- 576
3. ¼î±×·» ÁõÈıº(Sj?gren's syndrome) -------- 587
4. º£Ã¼Æ®º´(Beh?et's disease) -------- 594
5. Ç÷°ü¿°(Vasculitis) -------- 599
6. ôÃß °üÀýº´Áõ(Spondyloarthropathies, SpA): °­Á÷ ôÃß¿°(Ankylosing spondylitis, AS)/¹ÝÀÀ °üÀý¿°(Reactive arthritis, ReA) -------- 612
7. ·ù¸¶Æ¼½º °üÀý¿°(Rheumatoid arthritis, RA) -------- 621

SECTION 2. °üÀý°ú ÀÎÁ¢Á¶Á÷ Áúȯ -------- 634
1. °ñ°üÀý¿°(Osteoarthritis, OA) -------- 635
2. °áÁ¤ ¿¬°ü °üÀýº´Áõ: Åëdz(Gout)/°¡¼ºÅëdz(CPPD disease) -------- 648
3. °¨¿° °üÀý¿°(Infectious arthritis) -------- 668
4. ¼¶À¯±ÙÀ°Åë(Fibromyalgia, FM) -------- 673

PART 1. ¹ÙÀÌÅ»
SECTION 1. Cardiac arrest ¡æ ½ÉÆó¼Ò»ý¼úÀ» ½ÃÇàÇÏÀÚ!! -------- 2
1. ½ÉÆó¼Ò»ý¼ú: °³¿ä -------- 3
2. ¼ºÀÎ Àü¹® ½ÉÆó¼Ò»ý¼ú(Advanced Cardiovascular Life Support, ACLS) -------- 15

SECTION 2. Ç÷¾ÐÀÌ ºÒ¾ÈÁ¤ÇÑ °æ¿ì: ÃâÇ÷, ¼îÅ© ¹× ¼ö¾×¼Ò»ý¼ú -------- 32
1. ¼îÅ©: °³¿ä/Ä¡·á ¿øÄ¢ -------- 33
2. ÀúÇ÷·® ¼îÅ©/ÃâÇ÷¼º ¼îÅ©(Hypovolemic shock/Hemorrhagic shock) -------- 43
3. ÆÐÇ÷ ¼îÅ©(Septic shock) -------- 49
4. ½ÉÀ强 ¼îÅ©(Cardiogenic shock) -------- 58
5. ½Å°æ¼º ¼îÅ©(Neurogenic shock) -------- 63
6. ¼ö¾×¿ä¹ý(Fluid therapy) -------- 66
7. ¼öÇ÷¿ä¹ý(Transfusion) -------- 71

SECTION 3. È£ÈíÀÌ ºÒ¾ÈÁ¤ÇÑ °æ¿ì: ±âµµ ¹× ȯ±â°ü¸® -------- 83
1. È£Èí°ï¶õ¿¡ ´ëÇÑ Á¢±Ù -------- 84
2. »ê¼Ò¿ä¹ý -------- 94
3. ±âµµ ȯ±â/°ü¸® -------- 103
¤ý ºñħ½ÀÀû ±âµµ ȯ±â/°ü¸® -------- 104
¤ý ħ½ÀÀû ±âµµ ȯ±â/°ü¸®: ±â°ü »ð°ü -------- 112

SECTION 4. ¸Æ¹ÚÀÌ ºÒ¾ÈÁ¤ÇÑ °æ¿ì: ½É¹Ú¼ö/½ÉÀ帮µëÀå¾Ö -------- 122
1. ¼­¸Æ¿¡ ´ëÇÑ Á¢±Ù -------- 123
2. ºó¸Æ¿¡ ´ëÇÑ Á¢±Ù -------- 126

SECTION 5. ü¿ÂÀÌ»ó¿¡ ´ëÇÑ Á¢±Ù -------- 130
1. ¹ß¿­(Fever) -------- 131
¤ý ¹ß¿­¿¡ ´ëÇÑ Á¢±Ù -------- 132
¤ý ºÒ¸í¿­(Fever of unknown origin) -------- 139
2. Àúü¿Â(Hypothermia) -------- 148

PART 2. °¨¿°
SECTION 1. °¨¿°Áúȯ ±âº» -------- 158
1. ÁÖ¿ä º´¿øü¿¡ ´ëÇÑ ÀÌÇØ -------- 159
2. Ç×»ýÁ¦¿¡ ´ëÇÑ ÀÌÇØ -------- 161
3. ÀÇ·á °ü·Ã °¨¿° -------- 176
¤ý Ä«Å×ÅÍ °ü·Ã °¨¿°(Ä«Å×ÅÍ °ü·Ã ±ÕÇ÷Áõ) -------- 178
¤ý Clostridium difficile Infection [CDI, °ÅÁþ¸·´ëÀå¿°(Pseudomembranous colitis, PMC)] -------- 182

SECTION 2. °¨¿°°ü¸®/¿¹¹æ -------- 185
1. º´¿øüÀÇ Ä§ÀÔÀ» ¸·ÀÚ! -------- 186
2. ÀüÆÄ °úÁ¤À» Â÷´ÜÇÏÀÚ! -------- 195
¤ý Ç¥ÁØÁÖÀÇ(Standard precautions) -------- 196
¤ý ÀüÆÄ°æ·Îº° °Ý¸® ------- 202
3. ¸é¿ª·ÂÀ¸·Î ´ëºñÇÏÀÚ! ¿¹¹æÁ¢Á¾ -------- 206
¤ý ¿¹¹æÁ¢Á¾¿¡ ´ëÇÑ ÀÌÇØ -------- 207
¤ý ¿¹¹æÁ¢Á¾ÀÇ ¿øÄ¢ -------- 210
¤ý ¿¹¹æÁ¢Á¾ ÀÏÁ¤ »ìÆ캸±â! -------- 221

SECTION 3. º´¿øüº°: ¼¼±Õ °¨¿° -------- 227
1. ±×¶÷¾ç¼º±Õ °¨¿° -------- 228
¤ý Æ÷µµ¾Ë±Õ(Staphylococcus) °¨¿° -------- 229
¤ý »ç½½¾Ë±Õ(Streptococcus) °¨¿° -------- 233
¤ý Æó·Å¾Ë±Õ(Pneumococcus) °¨¿° -------- 237
¤ý Àå¾Ë±Õ(Enterococcus) °¨¿° -------- 241
¤ý Corynebacterium °¨¿°: µðÇÁÅ׸®¾Æ(Diphtheria) µî -------- 245
¤ý ¸®½ºÅ׸®¾Æ(Listeria) °¨¿° -------- 249
2. ±×¶÷À½¼º±Õ °¨¿° -------- 252
¤ý Neisseria °¨¿°: ¼ö¸·¾Ë±Õ(Meni
ngococcus) °¨¿° -------- 254
¤ý Neisseria °¨¿°: ÀÓ±Õ(Gonoccocus) °¨¿° -------- 258
¤ý Çì¸ðÇʷ罺/¸ð¶ô¼¿¶ó(Hemophilus/Moraxella) °¨¿° -------- 262
¤ý ³ì³ó±Õ/¿¡½Ã³×Åä¹ÚÅÍ(Pseudomonas/Acinetobacter) °¨¿° -------- 267
¤ý »ì¸ð³Ú¶ó(ÀåƼǪ½º)/½Ã°Ö¶ó(Salmonella/Shigella) °¨¿° -------- 273
¤ý ºñºê¸®¿À(Vibrio) °¨¿°: ÄÝ·¹¶ó/±âŸ ºñºê¸®¿À -------- 280
¤ý ±×¶÷À½¼º Àå³»¼¼±Õ(Gram negative enteric bacteria) °¨¿° -------- 286
¤ý ¹éÀÏÇØ/±âŸ º¸µ¥ÅÚ¶ó °¨¿° -------- 294
¤ý Ä·ÇʷιÚÅÍ/Ç︮ÄÚ¹ÚÅÍ °¨¿° -------- 300
¤ý ·¹Áö¿À³Ú¶ó °¨¿° -------- 304
3. ±âŸ ¼¼±Õ °¨¿° -------- 307
¤ý ¸¶ÀÌÄÚÇöóÁ/Ŭ¶ó¹Ìµð¾Æ °¨¿° -------- 308
¤ý ³ª¼±±Õ(Spirochetes) °¨¿° -------- 316
¤ý ¹Ì»ê¼Ò¼º/¹«»ê¼Ò¼º ¼¼±Õ °¨¿° -------- 321
¤ý ¸®ÄÉÂ÷ °¨¿°: ÂêÂê°¡¹«½Ãº´, Å¥¿­ µî -------- 329
4. ¹ÌÄÚ¹ÚÅ׸®¾Æ(°áÇÙ±Õ) °¨¿° ------- 333
¤ý °áÇÙÀÇ Áø´Ü ¹× Ä¡·á -------- 334
¤ý Àẹ°áÇÙ °¨¿° -------- 349
¤ý ºñ°áÇÙ Ç×»ê±Õ(Non-Tuberculous Mycobacterium, NTM) °¨¿° -------- 355

SECTION 4. ¹ÙÀÌ·¯½º °¨¿° -------- 363
1. »ç¶÷Ç츣Æ佺 ¹ÙÀÌ·¯½º(Herpesviridae) °¨¿° -------- 364
¤ý ´Ü¼øÆ÷Áø ¹ÙÀÌ·¯½º(Herpes simplex virus) °¨¿° -------- 365
¤ý ¼öµÎ-´ë»óÆ÷Áø ¹ÙÀÌ·¯½º(Varicella-Zoster virus) °¨¿° -------- 368
¤ý ¿¦½ºÅ¸Àι٠¹ÙÀÌ·¯½º(Epstein Barr virus) °¨¿° -------- 379
¤ý °Å´ë¼¼Æ÷ ¹ÙÀÌ·¯½º(Cytomegalovirus) °¨¿° -------- 382
2. »ç¶÷À¯µÎÁ¾ ¹ÙÀÌ·¯½º(Human papillomaviruses, HPVs) °¨¿° -------- 386
3. ÀÎÇ÷翣ÀÚ(Influenza) °¨¿° -------- 389
4. Àå ¹ÙÀÌ·¯½º(¿£Å×·Î ¹ÙÀÌ·¯½º, Enterovirus) °¨¿° -------- 397
5. Äڷγª ¹ÙÀÌ·¯½º(Coronavirus) °¨¿° -------- 404
¤ý Äڷγª ¹ÙÀÌ·¯½º °¨¿°: Overview -------- 405
¤ý [Special review] Äڷγª 19(COVID-19) °¨¿° -------- 409
6. ÀϺ»³ú¿° ¹ÙÀÌ·¯½º(Japanese encephalitis virus) -------- 418
7.°ø¼öº´(±¤°ßº´, Rabies)) -------- 421
8. HIV °¨¿°/ÈÄõ¸é¿ª°áÇÌÁõÈıº(AIDS) -------- .. 426
9. ÃÖ±Ù À¯ÇàÇÏ°í ÀÖ´Â ¹ÙÀÌ·¯½º °¨¿°/ÇØ¿ÜÀ¯ÀÔ ¹ÙÀÌ·¯½º °¨¿° -------- 435

SECTION 5. Áø±Õ °¨¿° -------- 442
1. Ä­µð´ÙÁõ(Candidiasis) -------- 443
2. Å©¸³ÅäÄÚÄí½ºÁõ(Cryptococcosis) -------- 448
3. ¾Æ½ºÆ丣±æ·ç½ºÁõ(Aspergillosis) -------- 451
4. ÅаõÆÎÀÌÁõ(Mucormycosis) -------- 456
5. ÆóÆ÷ÀÚÃæÁõ(Pneumocystis jirovecii) -------- 461
6. ±âŸ Áø±Õ °¨¿° -------- 466

SECTION 6. ±â»ýÃæ °¨¿° -------- 475
1. ¿¬Ãæ(Helminths): ¼±Ãæ·ù, ÈíÃæ·ù, Á¶Ãæ·ù -------- 476
2. ¿øÃæ(Protozoa): ¸»¶ó¸®¾Æ µî -------- 4
86

PART 3. Á¾¾ç
SECTION 1. Á¾¾çÁúȯÀÇ Á¢±Ù -------- 500
[supplement] ¾Ï¿¡ ´ëÇÑ ±âº»ÀûÀÎ ÀÌÇØ -------- 501
1. Á¾¾çÁúȯÀÇ ÀϹÝÀûÀÎ Á¢±ÙÀü·« -------- 504
2. ¾Ï °ËÁø -------- 508
3. Á¾¾ç Ç¥ÁöÀÚ(Tumor marker) -------- 511

SECTION 2. Á¾¾çÁúȯÀÇ Ä¡·á -------- 515
1. ¾Ï Ä¡·á ¿øÄ¢ -------- 516
2. Ä¡·á ¹ÝÀÀÀÇ Æò°¡ -------- 519
3. ¹æ»ç¼± Ä¡·á(Radiotherapy) -------- 525

SECTION 3. Ç×¾ÏÈ­Çпä¹ý -------- 529
1. Ç×¾ÏÈ­Çпä¹ýÀÇ ¿øÄ¢ -------- 530
2. ÁÖ¿ä Ç×¾ÏÁ¦ -------- 533
¤ý Conventional agents/È£¸£¸óÄ¡·áÁ¦ -------- 534
¤ý Ç¥ÀûÄ¡·áÁ¦(Target therapy) -------- 541
¤ý ¸é¿ªÄ¡·áÁ¦(Immunotherapy) -------- 543
3. °¡½¿ ÅëÁõ(Chest pain):Musculoskeletal origin -------- 304

SECTION 4. ¾Ï °ü·Ã Áõ»ó ¹× ÇÕº´Áõ °ü¸® -------- 545
1. ¾Ï¼º ÅëÁõ °ü¸® -------- 546
2. ±¸Á¶Àû/Æó¼â¼º ÇÕº´Áõ -------- 557
¤ý »ó´ëÁ¤¸ÆÁõÈıº(Superior vena cava syndrome) -------- 558
¤ý ¾Ç¼º ô¼ö¾Ð¹ÚÁõÈıº(Malignant spinal cord compression) -------- 559
3. Ä¡·á °ü·Ã ÇÕº´Áõ -------- 560
¤ý Á¾¾ç¿ëÇØÁõÈıº(Tumor lysis syndrome) -------- 560

PART 4. ·ù¸¶Æ¼½º
SECTION 1. ¸é¿ª¸Å°³Áúȯ -------- 564
1. Àü½Å È«¹Ý ·çǪ½º(Systemic lupus erythematosus, SLE) -------- 565
2. Àü½Å °æÈ­Áõ(Systemic sclerosis, SSc) -------- 576
3. ¼î±×·» ÁõÈıº(Sj?gren¡¯s syndrome) -------- 587
4. º£Ã¼Æ®º´(Beh?et¡¯s disease) -------- 594
5. Ç÷°ü¿°(Vasculitis) -------- 599
6. ôÃß °üÀýº´Áõ(Spondyloarthropathies, SpA): °­Á÷ ôÃß¿°(Ankylosing spondylitis, AS)/¹ÝÀÀ °üÀý¿°(Reactive arthritis, ReA) -------- 612
7. ·ù¸¶Æ¼½º °üÀý¿°(Rheumatoid arthritis, RA) -------- 621

SECTION 2. °üÀý°ú ÀÎÁ¢Á¶Á÷ Áúȯ -------- 634
1. °ñ°üÀý¿°(Osteoarthritis, OA) -------- 635
2. °áÁ¤ ¿¬°ü °üÀýº´Áõ: Åëdz(Gout)/°¡¼ºÅëdz(CPPD disease) -------- 648
3. °¨¿° °üÀý¿°(Infectious arthritis) -------- 668
4. ¼¶À¯±ÙÀ°Åë(Fibromyalgia, FM) -------- 673

ÀúÀÚ¼Ò°³

ÀÌ»óºÀ [Àú] ½ÅÀ۾˸² SMS½Åû
»ý³â¿ùÀÏ -

ÇØ´çÀÛ°¡¿¡ ´ëÇÑ ¼Ò°³°¡ ¾ø½À´Ï´Ù.

Àü°øµµ¼­/´ëÇб³Àç ºÐ¾ß¿¡¼­ ¸¹Àº ȸ¿øÀÌ ±¸¸ÅÇÑ Ã¥

    ¸®ºä

    0.0 (ÃÑ 0°Ç)

    100ÀÚÆò

    ÀÛ¼º½Ã À¯ÀÇ»çÇ×

    ÆòÁ¡
    0/100ÀÚ
    µî·ÏÇϱâ

    100ÀÚÆò

    0.0
    (ÃÑ 0°Ç)

    ÆǸÅÀÚÁ¤º¸

    • ÀÎÅÍÆÄÅ©µµ¼­¿¡ µî·ÏµÈ ¿ÀǸ¶ÄÏ »óÇ°Àº ±× ³»¿ë°ú Ã¥ÀÓÀÌ ¸ðµÎ ÆǸÅÀÚ¿¡°Ô ÀÖÀ¸¸ç, ÀÎÅÍÆÄÅ©µµ¼­´Â ÇØ´ç »óÇ°°ú ³»¿ë¿¡ ´ëÇØ Ã¥ÀÓÁöÁö ¾Ê½À´Ï´Ù.

    »óÈ£

    (ÁÖ)±³º¸¹®°í

    ´ëÇ¥ÀÚ¸í

    ¾Èº´Çö

    »ç¾÷ÀÚµî·Ï¹øÈ£

    102-81-11670

    ¿¬¶ôó

    1544-1900

    ÀüÀÚ¿ìÆíÁÖ¼Ò

    callcenter@kyobobook.co.kr

    Åë½ÅÆǸž÷½Å°í¹øÈ£

    01-0653

    ¿µ¾÷¼ÒÀçÁö

    ¼­¿ïƯº°½Ã Á¾·Î±¸ Á¾·Î 1(Á¾·Î1°¡,±³º¸ºôµù)

    ±³È¯/ȯºÒ

    ¹ÝÇ°/±³È¯ ¹æ¹ý

    ¡®¸¶ÀÌÆäÀÌÁö > Ãë¼Ò/¹ÝÇ°/±³È¯/ȯºÒ¡¯ ¿¡¼­ ½Åû ¶Ç´Â 1:1 ¹®ÀÇ °Ô½ÃÆÇ ¹× °í°´¼¾ÅÍ(1577-2555)¿¡¼­ ½Åû °¡´É

    ¹ÝÇ°/±³È¯°¡´É ±â°£

    º¯½É ¹ÝÇ°ÀÇ °æ¿ì Ãâ°í¿Ï·á ÈÄ 6ÀÏ(¿µ¾÷ÀÏ ±âÁØ) À̳»±îÁö¸¸ °¡´É
    ´Ü, »óÇ°ÀÇ °áÇÔ ¹× °è¾à³»¿ë°ú ´Ù¸¦ °æ¿ì ¹®Á¦Á¡ ¹ß°ß ÈÄ 30ÀÏ À̳»

    ¹ÝÇ°/±³È¯ ºñ¿ë

    º¯½É ȤÀº ±¸¸ÅÂø¿À·Î ÀÎÇÑ ¹ÝÇ°/±³È¯Àº ¹Ý¼Û·á °í°´ ºÎ´ã
    »óÇ°À̳ª ¼­ºñ½º ÀÚüÀÇ ÇÏÀÚ·Î ÀÎÇÑ ±³È¯/¹ÝÇ°Àº ¹Ý¼Û·á ÆǸÅÀÚ ºÎ´ã

    ¹ÝÇ°/±³È¯ ºÒ°¡ »çÀ¯

    ·¼ÒºñÀÚÀÇ Ã¥ÀÓ ÀÖ´Â »çÀ¯·Î »óÇ° µîÀÌ ¼Õ½Ç ¶Ç´Â ÈÑ¼ÕµÈ °æ¿ì
    (´ÜÁö È®ÀÎÀ» À§ÇÑ Æ÷Àå ÈѼÕÀº Á¦¿Ü)

    ·¼ÒºñÀÚÀÇ »ç¿ë, Æ÷Àå °³ºÀ¿¡ ÀÇÇØ »óÇ° µîÀÇ °¡Ä¡°¡ ÇöÀúÈ÷ °¨¼ÒÇÑ °æ¿ì
    ¿¹) È­ÀåÇ°, ½ÄÇ°, °¡ÀüÁ¦Ç°(¾Ç¼¼¼­¸® Æ÷ÇÔ) µî

    ·º¹Á¦°¡ °¡´ÉÇÑ »óÇ° µîÀÇ Æ÷ÀåÀ» ÈѼÕÇÑ °æ¿ì
    ¿¹) À½¹Ý/DVD/ºñµð¿À, ¼ÒÇÁÆ®¿þ¾î, ¸¸È­Ã¥, ÀâÁö, ¿µ»ó È­º¸Áý

    ·½Ã°£ÀÇ °æ°ú¿¡ ÀÇÇØ ÀçÆǸŰ¡ °ï¶õÇÑ Á¤µµ·Î °¡Ä¡°¡ ÇöÀúÈ÷ °¨¼ÒÇÑ °æ¿ì

    ·ÀüÀÚ»ó°Å·¡ µî¿¡¼­ÀÇ ¼ÒºñÀÚº¸È£¿¡ °üÇÑ ¹ý·üÀÌ Á¤ÇÏ´Â ¼ÒºñÀÚ Ã»¾àöȸ Á¦ÇÑ ³»¿ë¿¡ ÇØ´çµÇ´Â °æ¿ì

    »óÇ° Ç°Àý

    °ø±Þ»ç(ÃâÆÇ»ç) Àç°í »çÁ¤¿¡ ÀÇÇØ Ç°Àý/Áö¿¬µÉ ¼ö ÀÖÀ½

    ¼ÒºñÀÚ ÇÇÇغ¸»ó
    ȯºÒÁö¿¬¿¡ µû¸¥ ¹è»ó

    ·»óÇ°ÀÇ ºÒ·®¿¡ ÀÇÇÑ ±³È¯, A/S, ȯºÒ, Ç°Áúº¸Áõ ¹× ÇÇÇغ¸»ó µî¿¡ °üÇÑ »çÇ×Àº ¼ÒºñÀÚºÐÀïÇØ°á ±âÁØ (°øÁ¤°Å·¡À§¿øȸ °í½Ã)¿¡ ÁØÇÏ¿© 󸮵Ê

    ·´ë±Ý ȯºÒ ¹× ȯºÒÁö¿¬¿¡ µû¸¥ ¹è»ó±Ý Áö±Þ Á¶°Ç, ÀýÂ÷ µîÀº ÀüÀÚ»ó°Å·¡ µî¿¡¼­ÀÇ ¼ÒºñÀÚ º¸È£¿¡ °üÇÑ ¹ý·ü¿¡ µû¶ó ó¸®ÇÔ

    (ÁÖ)KGÀ̴Ͻýº ±¸¸Å¾ÈÀü¼­ºñ½º¼­ºñ½º °¡ÀÔ»ç½Ç È®ÀÎ

    (ÁÖ)ÀÎÅÍÆÄÅ©Ä¿¸Ó½º´Â ȸ¿ø´ÔµéÀÇ ¾ÈÀü°Å·¡¸¦ À§ÇØ ±¸¸Å±Ý¾×, °áÁ¦¼ö´Ü¿¡ »ó°ü¾øÀÌ (ÁÖ)ÀÎÅÍÆÄÅ©Ä¿¸Ó½º¸¦ ÅëÇÑ ¸ðµç °Å·¡¿¡ ´ëÇÏ¿©
    (ÁÖ)KGÀ̴Ͻýº°¡ Á¦°øÇÏ´Â ±¸¸Å¾ÈÀü¼­ºñ½º¸¦ Àû¿ëÇÏ°í ÀÖ½À´Ï´Ù.

    ¹è¼Û¾È³»

    • ±³º¸¹®°í »óÇ°Àº Åùè·Î ¹è¼ÛµÇ¸ç, Ãâ°í¿Ï·á 1~2Àϳ» »óÇ°À» ¹Þ¾Æ º¸½Ç ¼ö ÀÖ½À´Ï´Ù.

    • Ãâ°í°¡´É ½Ã°£ÀÌ ¼­·Î ´Ù¸¥ »óÇ°À» ÇÔ²² ÁÖ¹®ÇÒ °æ¿ì Ãâ°í°¡´É ½Ã°£ÀÌ °¡Àå ±ä »óÇ°À» ±âÁØÀ¸·Î ¹è¼ÛµË´Ï´Ù.

    • ±ººÎ´ë, ±³µµ¼Ò µî ƯÁ¤±â°üÀº ¿ìü±¹ Åù踸 ¹è¼Û°¡´ÉÇÕ´Ï´Ù.

    • ¹è¼Ûºñ´Â ¾÷ü ¹è¼Ûºñ Á¤Ã¥¿¡ µû¸¨´Ï´Ù.

    • - µµ¼­ ±¸¸Å ½Ã 15,000¿ø ÀÌ»ó ¹«·á¹è¼Û, 15,000¿ø ¹Ì¸¸ 2,500¿ø - »óÇ°º° ¹è¼Ûºñ°¡ ÀÖ´Â °æ¿ì, »óÇ°º° ¹è¼Ûºñ Á¤Ã¥ Àû¿ë